Equinix, Inc. Equity Method Investments decreased by 2.8% to $601.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.1%, from $546.00M to $601.00M. Over 4 years (FY 2020 to FY 2024), Equity Method Investments shows an upward trend with a 33.6% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $174.20M | $220.58M | $245.05M | $277.32M | $301.95M | $301.01M | $348.15M | $372.00M | $396.83M | $403.95M | $468.00M | $454.00M | $497.00M | $546.00M | $519.00M | $578.00M | $618.00M | $601.00M |
| QoQ Change | — | +26.6% | +11.1% | +13.2% | +8.9% | -0.3% | +15.7% | +6.9% | +6.7% | +1.8% | +15.9% | -3.0% | +9.5% | +9.9% | -4.9% | +11.4% | +6.9% | -2.8% |
| YoY Change | — | — | — | — | +73.3% | +36.5% | +42.1% | +34.1% | +31.4% | +34.2% | +34.4% | +22.0% | +25.2% | +35.2% | +10.9% | +27.3% | +24.3% | +10.1% |